Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Derek Hanson

2PUBLICATIONS

20CO-AUTHORS

Molecular targetsHaematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Jun 06, 2025

In silico drug sensitivity predicts subgroup-specific therapeutics in medulloblastoma patients.

Anna M Jermakowicz, Luz Ruiz, Jonathan Chu

|Jul 14, 2022

A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma.

Giselle Saulnier-Sholler, Dan G Duda, Genevieve Bergendahl

Pageof 1

Frequent Collaborators

1 joint publications

Giselle Saulnier-Sholler

1 joint publications

Dan G Duda

1 joint publications

Genevieve Bergendahl

1 joint publications

David Ebb

1 joint publications

Matija Snuderl

1 joint publications

Theodore W Laetsch

1 joint publications

Jennifer Michlitsch

1 joint publications

Michael S Isakoff

1 joint publications

Kevin Bielamowicz

1 joint publications

Jacqueline M Kraveka

Frequent Collaborators

1 joint publications

Giselle Saulnier-Sholler

1 joint publications

Dan G Duda

1 joint publications

Genevieve Bergendahl

1 joint publications

David Ebb

Top Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on : Apr 16, 2019

See more related videos

Top Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on : Apr 16, 2019

See more related videos